Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

CLIPPERS complicating multiple sclerosis causing concerns of CNS lymphoma.
Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing-remitting multiple sclerosis.
Hematopoietic stem cell transplantation for MS: extraordinary evidence still needed.
EMD Serono and Pfizer announce FDA approval of Rebif® Rebidose® (interferon beta-1a)
Decreased systemic IL-7 and soluble IL-7Rα in multiple sclerosis patients.
Neurons and astroglia govern microglial endotoxin tolerance through macrophage colony-stimulating factor receptor-mediated ERK1/2 signals.
Fumaric acid esters promote neuronal survival upon ischemic stress through activation of the Nrf2 but not HIF-1 signaling pathway.
Switching patients at high risk of PML from natalizumab to another disease-modifying therapy.
Intrathecal interferon reduces exacerbations of multiple sclerosis.
Rituximab for relapsing-remitting multiple sclerosis.
Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis.
Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.
Association Between Sleep Problems and Perceived Cognitive Dysfunction Over 12 Months in Individuals with Multiple Sclerosis.
Differential transcriptional response profiles in human myeloid cell populations.
Brain-gut axis and pentadecapeptide BPC 157. Theoretical and practical implications.
Dimethyl fumarate induces necroptosis in colon cancer cells through glutathione depletion/ROS increase/MAPKs activation pathway.
CinnoVex home page
The pathogenesis of demyelinating form of Guillain-Barre syndrome: proteo-peptidomic and immunological profiling of physiological fluids.
The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies.
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.
Dimethyl fumarate protects pancreatic islet cells and non-endocrine tissue in L-arginine-induced chronic pancreatitis.
Comparison of Betaferon, Avonex, and Rebif in treatment of relapsing-remitting multiple sclerosis.
Effects of dimethyl fumarate on lymphocyte subsets.
Hypovitaminosis D upscales B-cell immunoreactivity in multiple sclerosis.

Pages